Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (CLRB)

CUSIP: 15117F807

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 5 signals
Share change
+56,000
SEC-reported price per share
$0.41
Number of holders
1
Value change
+$23,000
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
43,754,363

Security key

15117F807

Report period

Q2 2022

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of CLRB - Cellectar Biosciences, Inc. - Common stock, par value $0.00001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
AIGH Capital Management LLC
Disclosed value leader
AIGH Capital Management LLC
Comparable rows
0/15
Latest evidence
31 Mar 2022
13F Highest disclosed value: $1,263,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

AIGH Capital Management LLC has the largest disclosed position value at $1.26M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens AIGH Capital Management LLC's linked filing trail.
Disclosed position value Top 5
AIGH Capital Management LLC $1.26M
VANGUARD GROUP INC $1.21M
BlackRock Finance, Inc. $489K
Worth Venture Partners, LLC $315K
GEODE CAPITAL MANAGEMENT, LLC $303K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$1,263,000
1,837,046 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$1,206,000
1,753,800 shares
— 31 Mar 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$489,000
712,679 shares
— 31 Mar 2022
Worth Venture Partners, LLC
13F
Company
13F
—
denominator unverified
$315,000
458,245 shares
— 31 Mar 2022
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$303,000
441,883 shares
— 31 Mar 2022
Maven Securities LTD
13F
Company
13F
—
denominator unverified
$275,000
400,000 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
56,000
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q2 2022 holders
1
Holder diff
0
Investor Q3 2025 Shares Q2 2022 Shares Share Diff Share Chg % Q3 2025 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .